Detection of T-regulatory cells has a potential role in the diagnosis of classical Hodgkin lymphoma

Cytometry Part B - Clinical Cytometry

Volumn 74, Issue 4, 2008, Pages 227-235

  Bosler, David S ^a   Douglas Nikitin, Vonda K ^b   Harris, Valerie N ^b   Smith, Marc D ^b  

^a MAYO CLINIC   (United States)

^b WILLIAM BEAUMONT HOSPITAL   (United States)

Author keywords

CD152; Flow cytometry; Hodgkin lymphoma; T regulatory cells

Indexed keywords

CD4 ANTIGEN; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; INTERLEUKIN 2 RECEPTOR ALPHA;

ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; B CELL LYMPHOMA; CANCER PATIENT; DIAGNOSTIC PROCEDURE; DIAGNOSTIC VALUE; FEMALE; FLOW CYTOMETRY; HODGKIN DISEASE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; SENSITIVITY AND SPECIFICITY; TUMOR DIFFERENTIATION;

ADULT; AGED; ANIMALS; ANTIGENS, CD; CD4-CD8 RATIO; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; FEMALE; FLOW CYTOMETRY; GRANULOMATOUS DISEASE, CHRONIC; HODGKIN DISEASE; HUMANS; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; LYMPH NODES; MALE; MIDDLE AGED; ROC CURVE; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES, REGULATORY;

EID: 47549110980     PISSN: 15524949     EISSN: 15524957     Source Type: Journal    
DOI: 10.1002/cyto.b.20407     Document Type: Article

References (29)

1. Martinez A, Aymerich M, Castillo M, Colomer D, Bellosillo B, Campo E, Villamor N. Routine use of immunophenotype by flow cytometry in tissues with suspected hematological malignancies. Cytometry Part B Clin Cytom 2003;56B:8-15.
2. Ravoet C, Demartin S, Gerard R, Dehon M, Peny MO, Petit B, Delannoy A, Husson B. Contribution of flow cytometry to the diagnosis of malignant and non malignant conditions in lymph node biopsies. Leuk Lymphoma 2004;45:1587-1593.
3. Weisberger J, Wu CD, Liu Z, Wong JY, Melamed MR, Darzynkiewicz Z, Gorczyca W. Differential diagnosis of malignant lymphomas and related disorders by specific pattern of expression of immunophenotypic markers revealed by multiparameter flow cytometry (Review). Int J Oncol 2000;17:1165-1177.
4. Nicol TL, Silberman M, Rosenthal DL, Borowitz MJ. The accuracy of combined cytopathologic and flow cytometric analysis of fine-needle aspirates of lymph nodes. Am J Clin Pathol 2000;114:18-28.
5. Fromm JR, Kussick SJ, Wood BL. Identification and purification of classical hodgkin cells from lymph nodes by flow cytometry and flow cytometric sorting. Am J Clin Pathol 2006;126:764-780.
6. Zeng G, Ewton A, Zu Y, An C, Nishino H, Ponce de Lion A, Chang C. Quantitative analysis of CD4/CD8 Ratios by flow cytometry as an adjunct in diagnosis of Hodgkin's lymphomas. Mod Pathol 2005;18 (Suppl 1):259a-260a.
7. Marshall NA, Christie LE, Munro LR, Culligan DJ, Johnston PW, Barker RN, Vickers MA. Immunosuppressive regulatory T cells are abundant in the reactive lymphocytes of Hodgkin lymphoma. Blood 2004;103:1755-1762.
8. Dariavach P, Mattéi MG, Golstein P, Leffanc MP. Human Ig superfamily CTLA-4 gene: Chromosomal localization and identity of protein sequence between murine and human CTLA-4 cytoplasmic domains. Eur J Immunol 1988;18:1901-1905.
9. Sansom D, Walker L. The role of CD28 and cytotoxic T-lymphocyte antigen-4 (CTLA-4) in regulatory T-cell biology. Immunol Rev 2006;212:131-148.
10. Dieckmann D, Plottner H, Berchtold S, Berger T, Schuler G. Ex vivo isolation and characterization of CD4+CD25+T cells with regulatory properties from human blood. J Exp Med 2001;193:1303-1310.
11. Lim HW, Hillsamer P, Banham ,AH, Kim ,CH. Cutting edge: Direct suppression of B cells by CD4+CD25+regulatory T cells. J Immunol 2005;175:4180-4183.
12. Ormandy LA, Hillemann T, Wedemeyer H, Manns MP, Greten TF, Korangy F. Increased populations of regulatory T cells in peripheral blood of patients with hepatocellular carcinoma. Cancer Res 2005;65:2457-2464.
13. McHugh RS, Shevach EM. The role of suppressor T cells in regulation of immune responses. J Allergy Clin Immunol 2002;110:693-702.
14. Beyer M, Schultze JL. Regulatory T cells in cancer. Blood 2006;108:804-811.
15. Woo EY, Yeh H, Chu CS, Schlienger K, Carroll RG, Riley JL, Kaiser LR, June CH. Cutting edge: Regulatory T cells from lung cancer patients directly inhibit autologous T cell proliferation. J Immunol 2002;168:4272-4276.
16. Liyanage UK, Moore TT, Joo HG, Tanaka Y, Herrmann V, Doherty G, Drebin JA, Strasberg SM, Eberlein TJ, Goedegebuure PS, Linehan DC. Prevalence of regulatory T cells is increased in peripheral blood and tumor microenvironment of patients with pancreas or breast adneocarcinoma. J Immunol 2002:169:2756-2761.
17. Ichihara F, Kono K, Takahashi A, Kawaida H, Hidemitsu S, Fujii H. Increased populations of regulatory T cells in peripheral blood and tumor-infiltrating lymphocytes in patients with gastric and esophageal cancers. Clin Cancer Res 2003;9:4404-4408.
18. Curiel TJ, Coukos G, Zou L, Alvarez X, Cheng P, Mottram P, Evdemon-Hogan M, Conejo-Garcia JR, Zhang L, Burow M, Zhu Y, Wei S, Kryczek I, Daniel B, Gordon A, Myers L, Lackner A, Disis ML, Knutson KL, Chen L, Zou W Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival. Nat Med 2004;10:942-949.
19. Schaefer C, Kim GG, Albers A, Hoermann K, Myers EN, Whiteside TL. Characteristics of CD4+CD25+regulatory T cells in the perpheral circulation of patients with head and neck cancer. Br J Cancer 2005;92:913-920.
20. Javia LR, Rosenberg SA. CD4+CD25+suppressor lymphocytes in the circulation of patients immunized against melanoma antigens. J Immunother 2003;26:85-93.
21. Yang ZZ, Novak AJ, Stenson MJ, Witzig TE, Ansell SM. Intratumoral CD4+CD25+regulatory Tcell-mediated suppression of infiltrating CD4+Tcells in B-cell non-Hodgkin lymphoma. Blood 2006;107:3639-3646.
22. Wang X, Zheng J, Liu J, Yao J, He Y, Li X, Yu J, Yang J, Liu Z, Huang S. Increased population of CD4(+)CD25(high), regulatory T cells with their higher apoptotic and proliferating status in peripheral blood of acute myeloid leukemia patients. Eur J Haematol 2005;75:468-476.
23. Prabhala RH, Neri P, Bae JE, Tassone P, Shammas MA, Allam CK, Daley JF, Chauhan D, Blanchard E, Thatte HS, Anderson KC, Munshi NC. Dysfunctional T regulatory cells in multiple myeloma. Blood 2006;107:301-304.
24. hi regulatory T cells in patients with chronic lymphocytic leukemia after therapy with fludarabine. Blood 2005;106:2018-2025.
25. Vandenborre K, Delabie J, Boogaerts MA, De Vos R, Lorre K, De Wolf-Peeters C, Vandenberghe E Human CTLA-4 is expressed in situ on T lymphocytes in germinal centers, in cutaneous graft-versus-host disease, and in Hodgkin's disease. Am J Path 1998;152:963-973.
26. Kosmaczewska A, Frydecka I, Bocko D, Ciszak L, Teodorowska R. Correlation of blood lymphocyte CTLA-4 (CD152) induction in Hodgkin's disease with proliferative activity, interleukin 2 and interferon-gamma production. Br J Haematol 2002;118:202-209.
27. Alvaro T, Lejeune M, Salvado MT, Bosch R, Garcia JF, Jaen J, Banham AH, Roncador G, Montalban C, Piris MA. Outcome in Hodgkin's lymphoma can be predicted from the presence of accompanying cytotoxic and regulatory T cells. Clin Cancer Res 2005;11:1467-1473.
28. Wilson WM, Dua U, Grigg AP, Gandhi MK. Correlation of T-cell immune response with spontaneous resolution and subsequent relapse of Hodgkin's lymphoma. Leuk Lymphoma 2006;46:871-876.
29. Ishida T, Ishii T, Inagaki A, Yano H, Komatsu H, Iida S, Inagaki H, Ueda R. Specific recruitment of CC chemokine receptor 4-positive regulatory T cells in Hodgkin lymphoma fosters immune privilege. Cancer Res 2006;66:5716-5722.